Sanofi maintains a 48.2% share, while state-owned investor Bpifrance holds the remaining 1.8%. Sanofi reported net cash proceeds of about 10 billion ($10.7 billion) from the deal, which it had ...

The chief executive of generic drugmaker Sandoz said a proposal by the CEOs of Novartis and Sanofi to introduce a Europe-wide list price for new medicines is "deeply flawed" and would not solve ...

Sanofi (NASDAQ:SNY) announced Tuesday that its TIDE-Asthma Phase 2 study for its T-cell-depleting monoclonal antibody amlitelimab didn’t reach the primary endpoint for the highest dose level but ...

Sanofi saw a 2.85% increase in its share price last week, coinciding with notable company updates. The pharmaceutical giant announced a dividend increase to €3.92 per share during its Annual ...